Enhanced sublingual immunotherapy by TAT-fused recombinant allergen in a murine rhinitis model

Volume: 48, Pages: 118 - 125
Published: Jul 1, 2017
Abstract
null null Allergen-specific sublingual immunotherapy (SLIT) is well known as an effective and non-invasive route to induce allergy desensitization. The goal of this study was to investigate whether a TAT-fused recombinant allergen could enhance SLIT efficacy. BALB/c mice sensitized to the main allergen (Che a 3) of null Chenopodium album null pollen were treated sublingually either with rChe a 3 (100 μg/dose) or rTAT-Che a 3 (100 μg/dose), two...
Paper Details
Title
Enhanced sublingual immunotherapy by TAT-fused recombinant allergen in a murine rhinitis model
Published Date
Jul 1, 2017
Volume
48
Pages
118 - 125
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.